secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001140361-24-050002
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics repays $30M of senior secured term loan, total debt reduced to $75M
--------------------------------------------------------------------------------

- Repaid $30M of original $62.5M term loan with Ares Capital using cash on hand.
- Total gross debt now $75M: $42.5M revolver plus $32.5M term loan outstanding.
- This is second paydown in four months; total gross debt reduced by 29%.
- Lowered interest expense expected to enhance near-term earnings growth potential.
- CEO cites confidence in sustained earnings growth and ongoing cash generation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/0001140361-24-050002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/ef20040424_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-050002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer